Market Closed -
Other stock markets
|
Pre-market 04:30:00 am | |||
73.00 USD | -1.63% |
|
74.64 | +2.25% |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 4.14TCr | 5.92TCr | 6.72TCr | 5.95TCr | 5.31TCr | |||||
Total Revenues | 4.14TCr | 5.92TCr | 6.72TCr | 5.95TCr | 5.31TCr | |||||
Cost of Goods Sold, Total | 3.86TCr | 5.56TCr | 6.33TCr | 5.47TCr | 4.98TCr | |||||
Gross Profit | 278.5Cr | 358.3Cr | 391.8Cr | 485.3Cr | 333.5Cr | |||||
Selling General & Admin Expenses, Total | 133.2Cr | 123.1Cr | 133.3Cr | 152.7Cr | 172.4Cr | |||||
Provision for Bad Debts | 5.1Cr | - | - | - | - | |||||
Other Operating Expenses | -1Cr | -70L | 2.3Cr | 5.4Cr | 4.8Cr | |||||
Other Operating Expenses, Total | 137.3Cr | 122.4Cr | 135.6Cr | 158.1Cr | 177.2Cr | |||||
Operating Income | 141.2Cr | 235.9Cr | 256.2Cr | 327.2Cr | 156.3Cr | |||||
Interest Expense, Total | -26Cr | -24Cr | -40Cr | -52Cr | -47Cr | |||||
Interest And Investment Income | 2.2Cr | 4.8Cr | 7.1Cr | 15Cr | 16Cr | |||||
Net Interest Expenses | -24Cr | -20Cr | -33Cr | -37Cr | -31Cr | |||||
Income (Loss) On Equity Invest. | - | - | - | 14Cr | -3.8Cr | |||||
Currency Exchange Gains (Loss) | 15Cr | -3.8Cr | -1.1Cr | 2Cr | -32Cr | |||||
Other Non Operating Income (Expenses) | 4Cr | 12Cr | 7.7Cr | 15Cr | 37Cr | |||||
EBT, Excl. Unusual Items | 135.9Cr | 225Cr | 229.6Cr | 321.4Cr | 126.2Cr | |||||
Restructuring Charges | - | - | - | - | - | |||||
Merger & Related Restructuring Charges | - | - | - | -11Cr | - | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | -2.9Cr | 21Cr | -3.5Cr | -2Cr | 90L | |||||
Gain (Loss) On Sale Of Assets | 9.8Cr | 33Cr | - | - | 20Cr | |||||
Asset Writedown | - | -22Cr | -16Cr | -5.8Cr | - | |||||
Insurance Settlements | - | - | - | - | 5.8Cr | |||||
Legal Settlements | -1.5Cr | - | - | - | - | |||||
Other Unusual Items | - | - | -3.9Cr | 2.9Cr | - | |||||
EBT, Incl. Unusual Items | 141.3Cr | 256.5Cr | 206.6Cr | 305.1Cr | 152.4Cr | |||||
Income Tax Expense | 25Cr | 40Cr | 39Cr | 71Cr | 34Cr | |||||
Earnings From Continuing Operations | 116.5Cr | 216.7Cr | 167.8Cr | 233.7Cr | 118.8Cr | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 116.5Cr | 216.7Cr | 167.8Cr | 233.7Cr | 118.8Cr | |||||
Minority Interest | -2Cr | -8.9Cr | -6.8Cr | -9.4Cr | -5.1Cr | |||||
Net Income - (IS) | 114.5Cr | 207.8Cr | 161Cr | 224.3Cr | 113.7Cr | |||||
Preferred Dividend and Other Adjustments | 2.4Cr | 3.4Cr | - | - | - | |||||
Net Income to Common Incl Extra Items | 112.1Cr | 204.4Cr | 161Cr | 224.3Cr | 113.7Cr | |||||
Net Income to Common Excl. Extra Items | 112.1Cr | 204.4Cr | 161Cr | 224.3Cr | 113.7Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 7.97 | 14.49 | 10.83 | 15.07 | 8.09 | |||||
Basic EPS - Continuing Operations | 7.97 | 14.49 | 10.83 | 15.07 | 8.09 | |||||
Basic Weighted Average Shares Outstanding | 14Cr | 14Cr | 15Cr | 15Cr | 14Cr | |||||
Net EPS - Diluted | 7.72 | 13.64 | 10.51 | 14.87 | 7.99 | |||||
Diluted EPS - Continuing Operations | 7.72 | 13.64 | 10.51 | 14.87 | 7.99 | |||||
Diluted Weighted Average Shares Outstanding | 15Cr | 15Cr | 15Cr | 15Cr | 14Cr | |||||
Normalized Basic EPS | 5.89 | 9.34 | 9.19 | 12.87 | 5.25 | |||||
Normalized Diluted EPS | 5.54 | 8.65 | 8.93 | 12.7 | 5.19 | |||||
Dividend Per Share | 2 | 2.08 | 2.4 | 2.61 | 2.72 | |||||
Payout Ratio | 27.6 | 15.54 | 21.68 | 17.08 | 33.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 184.7Cr | 278.3Cr | 297Cr | 372.3Cr | 203.1Cr | |||||
EBITA | 146.1Cr | 240.7Cr | 260.3Cr | 333.3Cr | 160Cr | |||||
EBIT | 141.2Cr | 235.9Cr | 256.2Cr | 327.2Cr | 156.3Cr | |||||
EBITDAR | 269.1Cr | 433.5Cr | 466.8Cr | 502.4Cr | 331.8Cr | |||||
Effective Tax Rate - (Ratio) | 17.55 | 15.52 | 18.78 | 23.4 | 22.05 | |||||
Current Domestic Taxes | -40L | 17Cr | 22Cr | 22Cr | 11Cr | |||||
Current Foreign Taxes | 18Cr | 50Cr | 29Cr | 50Cr | 24Cr | |||||
Total Current Taxes | 18Cr | 67Cr | 51Cr | 72Cr | 35Cr | |||||
Deferred Domestic Taxes | 3.3Cr | 1Cr | 2.9Cr | 4.6Cr | 1.8Cr | |||||
Deferred Foreign Taxes | 3.8Cr | -28Cr | -15Cr | -4.7Cr | -2.8Cr | |||||
Total Deferred Taxes | 7.1Cr | -27Cr | -12Cr | -10L | -1Cr | |||||
Normalized Net Income | 83Cr | 131.72Cr | 136.7Cr | 191.48Cr | 74Cr | |||||
Interest Capitalized | 10L | 20L | 30L | 1.9Cr | 4Cr | |||||
Non-Cash Pension Expense | 1.2Cr | -1.3Cr | -5.7Cr | -20L | -60L | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 2.4Cr | 3.3Cr | 3.3Cr | 3.5Cr | 3Cr | |||||
Net Rental Expense, Total | 84Cr | 155.2Cr | 169.8Cr | 130.1Cr | 128.7Cr | |||||
Imputed Operating Lease Interest Expense | 26Cr | 41Cr | 89Cr | 98Cr | 82Cr | |||||
Imputed Operating Lease Depreciation | 58Cr | 114.43Cr | 81Cr | 32Cr | 47Cr | |||||
Stock-Based Comp., Other (Total) | 7.1Cr | 6.1Cr | 6.5Cr | 6.9Cr | 6.5Cr | |||||
Total Stock-Based Compensation | 7.1Cr | 6.1Cr | 6.5Cr | 6.9Cr | 6.5Cr |
- Stock Market
- Equities
- BG Stock
- Financials Bunge Global SA
- Income Statement
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition